Lisbon

Lisbon has rapidly emerged as a premier European life sciences hub, distinguished by its unique integration of biotechnology startups, world-class academic research, and a burgeoning digital health ecosystem.

The city is globally recognized for its excellence in molecular medicine and oncology, anchored by prestigious institutions like the Gulbenkian Institute for Molecular Medicine (GIMM) and the Champalimaud Foundation.

As a strategic gateway for pharmaceutical companies eyeing expansion into Lusophone and European markets, Lisbon offers a highly qualified workforce and competitive clinical trial infrastructure.

The region’s healthcare innovation is increasingly defined by AI-driven diagnostics and medical device development, supported by specialized clusters like Health Cluster Portugal.

In 2026, Lisbon’s international profile reached new heights as the host of BIO-Europe Spring, highlighting its status as a magnet for venture capital investment and biopharma partnerships.

From scalable 3D-printed bioreactors to advanced healthtech platforms, the local startup scene is pioneering solutions for personalized medicine and sustainable biomanufacturing.

This thriving innovation district benefits from strong public-private collaborations, fostering a seamless transition from laboratory discovery to industrial-scale production.

By prioritizing digital transformation and interdisciplinary research, Lisbon has solidified its position as a resilient and forward-thinking destination for the global life sciences industry.